U.S., April 16 -- ClinicalTrials.gov registry received information related to the study (NCT06929065) titled 'Randomized Trial of HIFU vs. Cryo for Prostate Cancer' on Nov. 16, 2022.
Brief Summary: HIFU has been FDA approved and is widely utilized across the United States and Europe for the treatment of prostate cancer. Despite this, HIFU has not been offered within SCPMG until now due to growing patient demand. We have offered cryoablation. This pilot study will determine the efficacy of HIFU vs. cryoablation focal therapy for early stage prostate cancer within SCPMG. We hope to elucidate whether outcomes are similar between the two modalities.
Study Start Date: April 01, 2023
Study Type: INTERVENTIONAL
Condition:
Prostate Cancer
Pros...